ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Duke wins Avon-NCI funding.

October 31, 2003

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

NINDS Awards Grants For Brain Tumor Centers

December 11, 1992

House Members Who Voted for Veto

January 3, 1986

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991